Common questions about Megace (FAQ)
Q: Is Megace considered a chemotherapy drug?
A: Megace is classified as a synthetic progestin, which is a type of hormonal agent. Official labeling indicates that the medicine is used for the palliative treatment of advanced carcinoma and should not be used in lieu of standard procedures such as chemotherapy, radiation, or surgery.
Q: Can Megace be used as a primary cancer treatment?
A: According to regulatory documents, this medicine is indicated for the palliative treatment of advanced (recurrent, inoperable, or metastatic) carcinoma. It should not be used in place of primary treatments such as surgery or radiation.
Q: What is the difference between Megace and Megestrol Acetate?
A: Megace is the brand name for the active substance known as Megestrol Acetate. Megestrol Acetate is the chemical compound that acts as the medication's active ingredient.
Q: How quickly does Megace usually start to affect appetite?
A: Studies and clinical data suggest that the onset of weight gain, which is associated with increased appetite, may begin within two to four weeks of starting treatment.
Q: Does Megace work by the same method as other hormone-based medicines?
A: The medicine is a synthetic progestin, meaning it works by stimulating the body's progesterone receptors. While it exhibits this classical progestational activity, its precise anti-cancer mechanism and its full anti-estrogenic effects are not entirely understood in regulatory documents.
Q: Does taking Megace increase the risk of developing diabetes?
A: Regulatory warnings state that clinical cases of new onset diabetes mellitus have been reported in association with the chronic use of this medicine. The regulatory label also indicates that it may worsen a pre-existing diabetic condition.
Q: Are there any signs of blood clots that patients should be aware of?
A: Official product information indicates that the medicine carries a risk of thromboembolic phenomena (blood clots). Symptoms such as sudden difficulty breathing, chest pain, or swelling, redness, and pain in one leg are listed as adverse effects that require prompt medical attention.
Q: Does Megace cause changes to mood or mental state?
A: Mood changes have been reported as an adverse reaction. Additionally, symptoms such as depression and anxiety are associated with the risk of Cushing's syndrome, which has been reported with the medicine’s chronic use.
Q: Is it common to have fluid retention or swelling in the legs with Megace?
A: Edema (fluid retention) has been reported as an adverse reaction. However, official labeling notes that the common weight gain observed with the medicine is not necessarily due to fluid retention.
Q: Is it safe to take Megace with a blood thinner like Warfarin?
A: The medicine may increase the effects of the blood thinner Warfarin. Regulatory documents indicate that co-administration is associated with a requirement for close clinical and laboratory monitoring of blood clotting indices.
Q: Are there certain over-the-counter pain relievers that interact with Megace?
A: Official information indicates that the metabolism of Megestrol Acetate may be increased when combined with certain common non-prescription pain relievers like Acetaminophen. Regulatory labels include advice for patients to inform their provider of all over-the-counter medicines they are using.
Q: Can Megace be taken alongside Indinavir, an HIV medicine?
A: Co-administration of the medicine with the HIV drug Indinavir may significantly decrease the concentration of Indinavir in the body. The regulatory label states that the healthcare provider may need to consider adjusting the Indinavir dose if these two medicines are taken together.
Q: Is there a concern about combining Megace with other hormonal therapies?
A: Since this medicine is a hormonal agent, regulatory labels include advice for patients to inform their healthcare provider about all hormonal therapies they are currently taking. This includes those that contain estrogen, such as contraceptives or hormone replacement therapy (HRT).
Q: Why is Megace sometimes associated with 'moon face' or a rounded facial appearance?
A: Overt Cushing's syndrome, a condition that can cause a characteristic rounded or 'moon face' appearance, has been reported in association with the chronic use of the medicine.
Q: Is Megace known to interact with herbal supplements?
A: Official patient safety advisories include the statement that patients should inform their healthcare provider about all substances they are taking. This includes prescription medicines, over-the-counter products, and any herbal products or other supplements.
Q: What is the risk of having a change in vision while on Megace?
A: Visual disturbances are listed as a reported adverse reaction in clinical trial data.
Q: Does Megace affect sleep patterns, such as causing insomnia?
A: Trouble sleeping or insomnia is listed as a reported adverse reaction in official product information.
Q: Is there a common reason for Megace treatment to be stopped by the healthcare team?
A: Discontinuation is often considered due to the development of serious side effects, such as a thromboembolic event (blood clot). Treatment may also be stopped to manage the risk of adrenal insufficiency that can occur upon medicine withdrawal.
Q: Does Megace cause hair loss or thinning?
A: Alopecia, which is the medical term for hair loss or thinning, is listed as a reported adverse reaction in official product information.
Q: What kind of monitoring (blood tests, etc.) is typically done while taking Megace?
A: Official documentation mentions the need for close surveillance for cancer patients. Monitoring may involve checking for changes in blood sugar (due to diabetes risk) and evaluating for adrenal insufficiency or changes in blood clotting ability (if taking Warfarin).
Q: If someone forgets to take a dose, what is the general guidance on catching up?
A: General patient guidance indicates that if a dose is missed, it should be taken as soon as it is remembered. However, if it is close to the next scheduled dose, the guidance is to skip the missed dose, and not to take double or extra doses.
Q: Does Megace affect blood pressure levels?
A: High blood pressure, known medically as hypertension, is listed as a reported adverse reaction in official product information.
Q: Are there specific symptoms that require immediate medical attention while taking Megace?
A: Symptoms that require immediate medical attention include signs of a blood clot, such as sudden difficulty breathing or swelling and pain in a leg. Signs of a serious allergic reaction, such as swelling of the face, lips, or tongue, also require immediate attention as described in the warnings.
